SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0000936392-09-000144
Filing Date
2009-03-31
Accepted
2009-03-30 19:52:22
Documents
16
Period of Report
2008-12-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-K a51293e10vk.htm 10-K 528652
2 EX-10.57 a51293exv10w57.htm EX-10.57 8309
3 EX-10.58 a51293exv10w58.htm EX-10.58 10606
4 EX-10.59 a51293exv10w59.htm EX-10.59 12060
5 EX-10.60 a51293exv10w60.htm EX-10.60 6256
6 EX-10.61 a51293exv10w61.htm EX-10.61 6467
7 EX-10.62 a51293exv10w62.htm EX-10.62 13181
8 EX-10.63 a51293exv10w63.htm EX-10.63 6151
9 EX-10.64 a51293exv10w64.htm EX-10.64 13634
10 EX-10.65 a51293exv10w65.htm EX-10.65 11858
11 EX-23.1 a51293exv23w1.htm EX-23.1 2015
12 EX-31.1 a51293exv31w1.htm EX-31.1 7927
13 EX-31.2 a51293exv31w2.htm EX-31.2 7931
14 EX-32.1 a51293exv32w1.htm EX-32.1 4517
15 GRAPHIC a51293a5129301.gif GRAPHIC 10111
16 GRAPHIC a51293a5129302.gif GRAPHIC 4154
  Complete submission text file 0000936392-09-000144.txt   660932
Mailing Address 6455 NANCY RIDGE DR SAN DIEGO CA 92121
Business Address 6455 NANCY RIDGE DR SAN DIEGO CA 92121 8584526600
LA JOLLA PHARMACEUTICAL CO (Filer) CIK: 0000920465 (see all company filings)

IRS No.: 330361285 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 000-24274 | Film No.: 09715681
SIC: 2836 Biological Products, (No Diagnostic Substances)